DURABLE REMISSIONS WITH CONTROL OF CYTOKINE RELEASE SYNDROME (CRS) USING T CELLS EXPRESSING CD19 TARGETED CHIMERIC ANTIGEN RECEPTOR (CAR) CTL019 TO TREAT RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOID LEUKEMIA (ALL)

被引：1

作者：

Levine, B. L. ^{[1
,2
,3
]}

Maude, S. ^{[4
,5
,6
]}

Zheng, Z. ^{[1
,2
]}

Shaw, P. ^{[7
]}

Ambrose, D. ^{[1
]}

Aplenc, R. ^{[5
,6
]}

Barker, C. ^{[4
,5
,6
]}

Barrett, D. ^{[4
,5
,6
]}

Brogdon, J. ^{[8
]}

Callahan, C. ^{[5
,6
]}

Chen, F. ^{[1
]}

Chew, A. ^{[1
]}

Davis, M. M. Suhoski ^{[1
,2
]}

Fesnak, A. D. ^{[1
,2
]}

Finklestein, J. ^{[1
]}

Frey, N. ^{[8
]}

Lacey, S. ^{[1
]}

Lamontagne, A. ^{[1
,2
]}

Lewitt, L. ^{[1
,2
]}

Loew, A. ^{[8
]}

Marcucci, K. ^{[1
]}

Melenhorst, J. ^{[1
,2
]}

Motley, L. ^{[5
,6
]}

Mudambi, M. ^{[5
,6
]}

Nazimuddin, F. ^{[1
]}

O'Rourke, M. ^{[1
,2
]}

Porter, D. ^{[3
]}

Rheingold, S. R. ^{[5
,6
]}

Scholler, J. ^{[1
]}

Tayor, C. ^{[1
,2
]}

White, C. ^{[5
,6
]}

Wood, P. ^{[9
]}

Young, R. ^{[1
]}

Teachey, D. T. ^{[4
,5
,6
]}

June, C. ^{[1
,2
,3
]}

Grupp, S. ^{[3
,4
,5
,6
]}

机构：

[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA

[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA

[3] Abramson Canc Ctr, Philadelphia, PA USA

[4] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA

[5] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[6] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA

[7] Univ Penn, Biostat & Epidemiol, Philadelphia, PA 19104 USA

[8] Novartis Inst Biomed Res, Cambridge, MA USA

[9] Novartis Pharmaceut, Cell & Gene Therapies Unit, E Hanover, NJ USA

来源：

CYTOTHERAPY | 2016年 / 18卷 / 06期

关键词：

D O I：

10.1016/j.jcyt.2016.03.039

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

引用

页码：S14 / S15

页数：2

共 50 条

[31] Humanized CD19-targeted chimeric antigen receptor T (CAR-T) cells for relapsed/refractory pediatric acute lymphoblastic leukemia
Wang, Shiyuan
Wang, Xue
Ye, Chunying
Cheng, Hai
Shi, Ming
Chen, Wei
Qi, Kunming
Wang, Gang
Wu, Qingyun
Zeng, Lingyu
Li, Zhenyu
Jing, Guangjun
Zheng, Junnian
Xu, Kailin
Cao, Jiang
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : E162 - E165
[32] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
Maude, Shannon L.
Hucks, George E.
Self, Alix Eden
Talekar, Mala Kiran
Teachey, David T.
Baniewicz, Diane
Callahan, Colleen
Gonzalez, Vanessa
Nazimuddin, Farzana
Gupta, Minna
Frey, Noelle V.
Porter, David L.
Levine, Bruce L.
Melenhorst, Jan J.
Lacey, Simon F.
June, Carl H.
Grupp, Stephan A.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[33] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
Curran, Kevin
PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
[34] Cytokine release syndrome and relevant factors of CD19 targeted chimeric antigen receptor T cell therapy in relapsed/refractory B cell hematological malignancies
Xu, Qian-wen
Xu, Hui
Xue, Lei
Wang, Li
Zhang, Xu-han
Yao, Wen
Wan, Xiang
Tong, Juan
Liu, Hui-lan
Liu, Xin
Zhu, Xiao-yu
Sun, Zi-min
Wang, Xing-bing
TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (06)
[35] Efficacy and Safety of Humanized Chimeric Antigen Receptor (CAR)-Modified T Cells Targeting CD19 in Children with Relapsed/Refractory ALL
Maude, Shannon L.
Barrett, David M.
Ambrose, David E.
Rheingold, Susan R.
Aplenc, Richard
Teachey, David T.
Callahan, Colleen
Barker, Christine S.
Mudambi, Maya
Shaw, Pamela A.
Brogdon, Jennifer
Young, Regina M.
Scholler, John
Loew, Andreas
Marcucci, Katherine T.
Finklestein, Jeffrey
Kulikovskaya, Irina
Nazimuddin, Farzana
Zheng, Zhaohui
Levine, Bruce L.
Porter, David L.
Lacey, Simon F.
Melenhorst, Jan J.
June, Carl H.
Grupp, Stephan A.
BLOOD, 2015, 126 (23)
[36] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Gu, Runxia
Liu, Fang
Zou, Dehui
Xu, Yingxi
Lu, Yang
Liu, Bingcheng
Liu, Wei
Chen, Xiaojuan
Liu, Kaiqi
Guo, Ye
Gong, Xiaoyuan
Lv, Rui
Chen, Xia
Zhou, Chunlin
Zhong, Mengjun
Wang, Huijun
Wei, Hui
Mi, Yingchang
Qiu, Lugui
Lv, Lulu
Wang, Min
Wang, Ying
Zhu, Xiaofan
Wang, Jianxiang
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[37] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
Runxia Gu
Fang Liu
Dehui Zou
Yingxi Xu
Yang Lu
Bingcheng Liu
Wei Liu
Xiaojuan Chen
Kaiqi Liu
Ye Guo
Xiaoyuan Gong
Rui Lv
Xia Chen
Chunlin Zhou
Mengjun Zhong
Huijun Wang
Hui Wei
Yingchang Mi
Lugui Qiu
Lulu Lv
Min Wang
Ying Wang
Xiaofan Zhu
Jianxiang Wang
Journal of Hematology & Oncology, 13
[38] Could cytokine release syndrome induce acute myelofibrosis in CD19 chimeric antigen receptor T cells therapy?
Lai, Xun
Sun, Yun Yan
Chang, Lung Ji
Ma, Yu Ru
Gu, Xue Zhong
Yao, Xiang Mei
Nie, Bo
Wen, Yan
Zhang, Xue Mei
Jiang, Ya Xian
Yang, Hui
Yu, Li Qun
Fang, Ming Jing
Wang, Ling
Bo, Xue Yuan
BIOENGINEERED, 2020, 11 (01) : 824 - 828
[39] HUMANIZED CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELTS TARGETING CD19 INDUCE REMISSIONS IN CHILDREN AND YOUNG ADULTS WITH RELAPSED/REFRACTORY LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Hucks, G. E.
Barrett, D.
Rheingold, S. R.
Aplenc, R.
Teachey, D. T.
Callahan, C.
Baniewicz, D.
White, C.
Talekar, M.
Shaw, P.
Brogdon, J. L.
Young, R.
Scholler, J.
Marcucci, K.
Chew, A.
Levine, B. L.
Frey, N.
Porter, D.
Lacey, S.
Melenhorst, J.
June, C.
Grupp, S.
Maude, S.
CYTOTHERAPY, 2017, 19 (05) : S9 - S10
[40] Biomarkers Accurately Predict Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Acute Lymphoblastic Leukemia (ALL)
Teachey, David T.
Lacey, Simon F.
Shaw, Pamela A.
Melenhorst, J. Joseph
Frey, Noelle V.
Maude, Shannon L.
Barrett, David M.
Aplenc, Richard
Chen, Fang
Fitzgerald, Julie
Gonzalez, Vanessa
Pequignot, Edward
Rheingold, Susan R.
Weiss, Scott
White, Jason C.
June, Carl H.
Porter, David L.
Grupp, Stephan A.
BLOOD, 2015, 126 (23)

← 1 2 3 4 5 →